Clinician-Approved: Our expert Clinical Team knows the challenges of GLP-1 medications
It reduces pain, restores motor functions, and reduces autonomic dysfunction by promoting healing in the peripheral nervous system
According to NICE guidance (NG28) , GLP-1 agonists are recommended for type 2 diabetes when metformin and other treatments have not achieved adequate control
It also supports bone growth and development, which is especially helpful for those who participate in endurance sports such as running, cycling, swimming,
BSO reduces GSH pools to below 1% in many cell types 25,26 and is generally well tolerated, including in studies on other intracellular bacteria where it was used at millimolar concentrations 15,17